BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Dow
UBS
Cerilliant
Express Scripts
AstraZeneca
Farmers Insurance
Accenture
Cipla
Julphar

Generated: January 20, 2018

DrugPatentWatch Database Preview

Norethindrone - Generic Drug Details

« Back to Dashboard

What are the generic sources for norethindrone and what is the scope of norethindrone patent protection?

Norethindrone
is the generic ingredient in twelve branded drugs marketed by Parke Davis, Mayne Pharma, Glenmark Generics, Aurobindo Pharma Ltd, Lupin Ltd, Janssen Pharms, Apil, Accord Hlthcare, Amneal Pharms, Mylan Labs Ltd, Novast Labs, Novast Labs Ltd, Duramed Res, and Barr, and is included in twenty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-six drug master file entries for norethindrone. Eighteen suppliers are listed for this compound. There are three tentative approvals for this compound.
Pharmacology for norethindrone
Ingredient-typeProgesterone Congeners
Drug ClassProgestin
Medical Subject Heading (MeSH) Categories for norethindrone
Tentative approvals for NORETHINDRONE
Applicant Application No. Strength Dosage Form
➤ Subscribe➤ Subscribe1MG;0.01MG;75MGTABLET;ORAL
➤ Subscribe➤ Subscribe1MG;0.02MGTABLET;ORAL
➤ Subscribe➤ Subscribe75MGTABLET;ORAL

US Patents and Regulatory Information for norethindrone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms NORETHINDRONE norethindrone TABLET;ORAL-28 202260-001 Aug 1, 2013 AB1 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glenmark Generics NORETHINDRONE ACETATE norethindrone acetate TABLET;ORAL 091090-001 Jul 21, 2010 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Apil NOR-QD norethindrone TABLET;ORAL-28 017060-001 Approved Prior to Jan 1, 1982 AB1 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mayne Pharma ERRIN norethindrone TABLET;ORAL-28 076225-001 Oct 21, 2002 AB2 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lupin Ltd NORETHINDRONE norethindrone TABLET;ORAL-28 091325-001 Sep 19, 2011 AB1 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Labs Ltd NORETHINDRONE norethindrone TABLET;ORAL-28 201483-001 Jun 24, 2013 AB1 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Janssen Pharms MICRONOR norethindrone TABLET;ORAL-28 016954-001 Approved Prior to Jan 1, 1982 AB2 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Novast Labs NORETHINDRONE norethindrone TABLET;ORAL-28 200961-001 Sep 13, 2013 AB2 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Parke Davis NORLUTATE norethindrone acetate TABLET;ORAL 012184-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mayne Pharma CAMILA norethindrone TABLET;ORAL-28 076177-001 Oct 21, 2002 AB1 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Teva
Boehringer Ingelheim
Baxter
Chubb
Fish and Richardson
Argus Health
Daiichi Sankyo
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot